925PAnalysis of response to prior therapies and therapies after treatment with erdafitinib in fibroblast growth factor receptor (FGFR)-positive patients (pts) with metastatic urothelial carcinoma (mUC)
Siefker-Radtke, A, Zhong, B, Qi, K, Shalaby, W, De Porre, P, O’Hagan, A, Mahadevia, P, Loriot, YVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz249.024
Date:
October, 2019
File:
PDF, 90 KB
2019
File converter
More search results
More benefits 
